Christoph B. Olivier: Rapid Platelet Inhibition in Acute Coronary Syndromes
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Heart Journal. Acute Cardiovascular Care:
“I am glad to share our upcoming paper ‘Injectable antiplatelet therapies in acute coronary syndromes: Current status and Emerging Therapies’.
This review provides a complete overview of parenteral antiplatelet management in ACS:
Parenteral P2Y12 inhibitors and GPIIb/IIIa inhibitors: Instantaneous platelet inhibition when oral route absorption is delayed or unviable.
Pre-hospital administration: Potential clinical benefits of early subcutaneous candidates.
Clinical decision-making: Practical timing, dosing strategies, and safety considerations in acute settings.
Proud to work alongside first author Uwe Zeymar and all the co-authors Sogol Koolaji, Diego Araiza Garaygordobil,Peter Clemmensen, Mario Gramegna , Konstantin Krychtiuk, Andrea Rubboli, Benedikt Schrage, Christophe Vandenbriele, Kurt Huber and Diana Gorog.”
Title: Injectable antiplatelet therapies in acute coronary syndromes: Current status and Emerging Therapies. A position paper of the Task Force of Antithrombotic therapy of the ACVC
Authors: Uwe Zeymer, Sogol Koolaji, Diego Araiza-Garaygordobil, Peter Clemmensen, Mario Gramegna, Konstantin A Krychtiuk, Christoph B Olivier, Andrea Rubboli, Benedikt Schrage, Christophe Vandenbriele, Kurt Huber, Diana A Gorog
Other posts featuring Christoph B. Olivier on Hemostasis Today.
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union